• About
  • Subscribe
  • Advertise
  • Contact
Tuesday, May 20, 2025
Newsletter
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
No Results
View All Results
Home Soapbox

The future of cataract surgery – A/Prof Michael Lawless

by Staff Writer
December 11, 2023
in Cataract, Eye disease, Feature, Intraocular lenses (IOLs), Laser treatments, News, Ophthalmology, Report, Soapbox
Reading Time: 5 mins read
A A
The future of cataract surgery, according to A/Prof Michael Lawless, is already here. Image: Vision Eye Institute

The future of cataract surgery, according to A/Prof Michael Lawless, is already here. Image: Vision Eye Institute

Share on FacebookShare on Twitter

I was asked to talk at the recent Ophthalmology Updates! meeting in Sydney on the near future for cataract and refractive surgery. I began with a quote from William Gibson: “The future is already here; it’s just not very evenly distributed”. As part of that I reminded ophthalmologists that with cataract surgery, if they are comfortable with what they’re doing, then they probably need to look up, and look around, because somebody’s doing something better.

I concentrated firstly on EDOF intraocular lenses (IOLs) and urged ophthalmologists to look at the underlying optical principles behind the various lenses available and those coming to market. Some are truly innovative, others are simply modifications of multifocal IOLs and some are not even EDOF lenses at all; but if we understand the optical principles we can make sensible clinical decisions about which to use in our practice, and not be persuaded one way or the other by industry.

I also emphasised the dilemma ophthalmologists have, for example, using the Vivity IOLs, which is probably the most widely used EDOF lens in Australia at present.  If I achieve a bilateral emmetropic end point in patient A and the same emmetropic end point in patient B, then Patient A may not require glasses for any activities, whereas Patient B might require +1.50 readers for near tasks. Exactly the same refractive end point with the same lenses and some people get better unaided near and intermediate vision than others. Why is that? It can be frustrating.

Dr Chris Hodge and I have studied my patients and have looked at all the variables via a multiple regression analysis, and have come up with an initial finding that pupil size is a significant indicator; that is, the smaller the natural pupil the better the unaided near vision will be, other things being equal. A cornea which has more spherical aberration likewise has a trend to better unaided near vision in this post-op circumstance. There will be other factors and perhaps combinations of factors, but over the next year we will be able to better predict patient function if we achieve a targeted end point. The same will almost certainly be true for regular aspheric monofocal lenses, and it will help us to use these better in the context of mini monovision.

I also talked about attempts to use large data sets and artificial intelligence to help with IOL selection. I used, as an example, the ZEISS Veracity surgical planner, which is not available in Australia yet, but is widely used in the US. It takes pre-operative information from the patient, both in terms of their lifestyle and expectations from surgery, combines this with the regular diagnostics and imaging of the eye, and in the mix are the lenses; the specific IOLs that a particular surgeon likes to use. The system is close to coming up with a recommended lens for a particular patient based on their lifestyle and their ocular anatomy.

I posed the conflict that will occur if surgeons have a very limited range of lenses. For example, if they never use a trifocal or an EDOF but only use monofocal lenses, then they will keep being offered monofocal lenses. If they widen their suite of lenses to what is actually available for patients, then almost certainly they will be recommended lenses they do not normally use. It will force ophthalmologists to consider a wider range of lenses and I think will be quite confronting. If in the end you as a surgeon are rejecting the lens chosen by ZEISS Veracity in favour of a more “conservative” lens, then you, the ophthalmologist, may be the problem (or barrier) to patients getting the lens best suited to their personality and lifestyle, rather than the problem being the artificial intelligence program. Something to consider.

Finally I talked about immediate sequential bilateral cataract surgery (ISBCS); that is, doing both eyes on the same day under set protocols. There is really no clinical reason not to adopt this for the majority of patients. There are plenty of reasons to adopt it:  efficiency, less waste of resources, cost, less disruption to relatives and carers, even less traffic on the roads. The barriers are financial and cultural, and ophthalmology in Australia will be forced to consider this with more seriousness in the near future.

Given that I started with suggesting the future is already here, bilateral same day cataract surgery is a good example, commonly performed in the Nordic countries and by enthusiast surgeons in different parts of the world, but rarely in Australia at present.

The near future is ours to grasp, and it looks challenging and promising. 

About the author

Name: A/Prof Michael Lawless
Qualifications: MB,BS. FRACS. FRANZCO
Affiliations: Clinical Associate Professor, University of Sydney. Ophthalmologist, Vision Eye Institute
Location: Sydney
Years in industry: 40

More reading

Myopia management is more than clinical acumen – Matt Oerding

AI, fundus imaging and life-threatening headaches

Registries and real world findings – A/Prof Mitchell Lawlor

Related Posts

geographic atrophy treatments

Exploring geographic atrophy: Managing patients and progress in treatments

by Rob Mitchell
May 20, 2025

At the completion of this article, the reader should be able to: Manage patient expectations and adherence to treatment, in...

Esther Ndukwe. Image: Specsavers.

Specsavers Stories – Esther Ndukwe

by Staff Writer
May 20, 2025

When people decide to work at Specsavers, they’re joining a company with a purpose to change lives through better sight and...

The company has developed an “age-related myopia management lens solution”. Image: ZEISS.

New ZEISS MyoCare myopia lens data

by Staff Writer
May 20, 2025

The latest one-year and two-year results from the ongoing multi-centre trials of ZEISS MyoCare lenses consistently demonstrate the slowing of...

Join our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

Insight has been the leading industry publication in Australia for more than 40 years. This longevity is largely due to our ability to consistently deliver accurate and independent news relevant to all ophthalmic professionals and their supporting industry.

Subscribe to our newsletter

View our privacy policy, collection notice and terms and conditions to understand how we use your personal information.

About Insight

  • About
  • Advertise
  • Subscribe
  • Contact
  • Terms & Conditions
  • Privacy Collection Notice
  • Privacy Policy

Popular Topics

  • Business
  • Feature
  • Research
  • Technology
  • Therapies
  • Classifieds

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited

No Results
View All Results
NEWSLETTER
SUBSCRIBE
  • Latest News
  • All Sections
    • Ophthalmic insights
      • Policy & regulation
      • Company updates & acquisitions
      • Research
      • Clinical trials
      • Workforce
      • Product approvals
      • Conferences
      • Opinion
      • Indigenous eye health
      • Retail
    • Eye disease
      • Dry eye
      • Myopia
      • Cataract
      • Glaucoma
      • Macular disease – AMD
      • Diabetic eye disease
      • Inherited retinal disease
      • Corneal disease
      • Presbyopia
      • Eye infections
    • Ophthalmic Careers
      • New appointments
      • Industry profiles
      • Graduates
    • Ophthalmic organisations
      • Regulators
      • Optometry networks
      • Private ophthalmology clinics
      • Associations
      • Patient support bodies
      • Eye research institutions
      • Optometry schools
      • Optical Dispensing trainers
      • Medical schools
      • RANZCO
  • Features
    • Report
    • Soapbox
  • Ophthalmic education
    • CPD – Optometry
    • Optical Dispensing
    • Orthoptics Australia
    • Practice management
  • Products
    • Ophthalmic Treatments
      • Ophthalmic lenses
      • Lens treatments
      • Myopia interventions
      • Light-based therapy
      • Minimally invasive glaucoma surgery (MIGS)
      • Gene therapy
      • Laser treatments
      • Supplements
      • Eyewear & frames
      • Behavioural optometry/vision training
      • Contact lenses
      • Anti-VEGF
      • Intraocular lenses (IOLs)
      • Pharmaceuticals & consumables
    • Ophthalmic equipment & diagnostics
      • Biometry – axial length
      • Perimetry & visual fields
      • OCT
      • Phoropter
      • Autorefractor
      • Tonometry
      • Topography
      • Multimodal imaging
      • Retinal imaging
      • Anterior segment imaging
      • Software & data management
      • Microscopes
      • Slit lamps
      • Lens edging
      • Stands, chairs and tables
      • Ultrasound
      • Dry eye diagnostics
      • Low vision aids
  • Research
  • Classifieds
  • About Us
  • Advertise with Insight
  • Subscribe
  • Contact Insight

© 2025 All Rights Reserved. All content published on this site is the property of Prime Creative Media. Unauthorised reproduction is prohibited